Bio-Connect
Chemical Structure
Chemical Structure
Chemical Structure

5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone

Research Use Only
CDX-E0533
Chemodex
CAS Number403811-55-2
Product group Chemicals
Estimated Purity>95%
Molecular Weight249.35
Price on request
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Chemodex
  • Product Name
    5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone [403811-55-2]
  • Delivery Days Customer
    10
  • CAS Number
    403811-55-2
  • Certification
    Research Use Only
  • Estimated Purity
    >95%
  • Molecular Formula
    C12H11NOS2
  • Molecular Weight
    249.35
  • Scientific Description
    c-Myc is a proto-oncogene that plays an important role in cell proliferation, differentiation, and apoptosis. 5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone [10058-F4] is a cell-permeable thiazolidinone compound that specifically inhibits the c-Myc-Max interaction/dimerization at 64 microM, preventing c-Myc-dependent gene expression and cell proliferation. 10058-F4 inhibits tumor cell growth and proliferation in a c-Myc-dependent manner both in vitro and in vivo. 10058-F4 induces cell-cycle arrest (G0/G1 phase) and apoptosis. 10058-F4 has been found to also upregulate cyclin-dependent kinase (CDK) inhibitors, p21 and p27. In addition to c-Myc, 10058-F4 inhibits the nuclear Myc protein, N-Myc, at 50 microM, inducing arrest, apoptosis, and differentiation in neuroblastoma cells overexpressing the gene for N-Myc. This compound can be used to delineate novel actions of Myc proteins, especially those related to lipid and glucose metabolism. 10058-F4 downregulates human telomerase reverse transcriptase and enhances chemosensitivity in several human cancer cell lines. - Chemical. CAS: 403811-55-2. Formula: C12H11NOS2. MW: 249.35. c-Myc is a proto-oncogene that plays an important role in cell proliferation, differentiation, and apoptosis. 5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone [10058-F4] is a cell-permeable thiazolidinone compound that specifically inhibits the c-Myc-Max interaction/dimerization at 64 microM, preventing c-Myc-dependent gene expression and cell proliferation. 10058-F4 inhibits tumor cell growth and proliferation in a c-Myc-dependent manner both in vitro and in vivo. 10058-F4 induces cell-cycle arrest (G0/G1 phase) and apoptosis. 10058-F4 has been found to also upregulate cyclin-dependent kinase (CDK) inhibitors, p21 and p27. In addition to c-Myc, 10058-F4 inhibits the nuclear Myc protein, N-Myc, at 50 microM, inducing arrest, apoptosis, and differentiation in neuroblastoma cells overexpressing the gene for N-Myc. This compound can be used to delineate novel actions of Myc proteins, especially those related to lipid and glucose metabolism. 10058-F4 downregulates human telomerase reverse transcriptase and enhances chemosensitivity in several human cancer cell lines.
  • SMILES
    O=C(NC(S/1)=S)C1=C/C2=CC=C(CC)C=C2
  • Storage Instruction
    2°C to 8°C,RT
  • UNSPSC
    12352200